Loading…
Oculis Holding AG is projected to rise to $19.03 by 2027, a +40% move from its current price of $13.63. OCS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $13.19 | $13.64 | $14.11 | +0.09% |
| Jul 14 | $13.01 | $13.65 | $14.32 | +0.18% |
| Jul 15 | $12.89 | $13.67 | $14.49 | +0.26% |
| Jul 16 | $12.78 | $13.68 | $14.64 | +0.35% |
| Jul 17 | $12.69 | $13.69 | $14.77 | +0.44% |
| Jul 18 | $12.61 | $13.70 | $14.89 | +0.53% |
| Jul 19 | $12.54 | $13.71 | $15.00 | +0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.54 | $13.71 | $15.00 | +0.62% |
| Week 2 | $12.15 | $13.80 | $15.67 | +1.24% |
| Week 3 | $11.89 | $13.88 | $16.22 | +1.86% |
| Week 4 | $11.67 | $13.97 | $16.72 | +2.49% |
| Week 5 | $11.50 | $14.06 | $17.18 | +3.12% |
| Week 6 | $11.35 | $14.14 | $17.62 | +3.76% |
| Week 7 | $11.22 | $14.23 | $18.04 | +4.40% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oculis Holding AG is a clinical-stage biopharmaceutical company focused on ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. Its lead product candidates include OCS-01, a topical dexamethasone optireach formulation, in Phase 3 for diabetic macular edema; OCS-02, a topical biologic candidate in Phase 2b for dry eye disease; and OCS-05, a disease-modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023.
The company was founded in 2017 and is based in Zug, Switzerland.
Current price is $14.12, and the market cap is $852.68M. The asset is ranked 2597.
A major floor 21.4% below — a decisive break under it would weaken the trend.
The nearest floor, 21.4% below — buyers have tended to step in here.
The nearest ceiling, 117.5% above — a clean break opens room to run.
A major ceiling 171.0% above — clearing it would confirm fresh momentum.
Key OCS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OCS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.68 | Sell | $13.63 | Buy |
| MA 10 | $13.50 | Buy | $13.40 | Buy |
| MA 20 | $12.47 | Buy | $13.87 | Sell |
| MA 50 | $19.74 | Sell | $17.62 | Sell |
| MA 100 | $23.44 | Sell | $20.59 | Sell |
| MA 200 | $22.52 | Sell | $21.42 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.86 | Neutral |
| Stoch RSI (14) | 88.30 | Sell |
| CCI (20) | 71.81 | Neutral |
| Williams %R (14) | -19.14 | Info |
| MACD (12,26,9) | 0.72 | Buy |
| ROC (12) | 16.30 | Buy |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 80.86 | Sell |
| TRIX (15) | -1.85 | Sell |
| Awesome (5,34) | -1.54 | Sell |
| Ultimate (7,14,28) | 50.04 | Neutral |
| Momentum (10) | 1.89 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 13.68 | Sell |
| ADX (14) | 29.93 | Sell |
| ATR (14) | 0.53 | Info |
The 30-day technical picture is bullish, with RSI14 at 40. The moving averages place the price below both the SMA50 ($21.07) and the SMA200 ($22.61). The 30-day range runs from $10.92 to $18.25, and the price faces support at $10.71 and resistance at $31.00. The annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.71 | $13.63 | $20.27 | 0% | Neutral | |
| $14.81 | $19.03 | $26.07 | +40% | Bullish | |
| $17.43 | $23.21 | $33.23 | +70% | Bullish | |
| $17.67 | $24.23 | $35.92 | +78% | Bullish | |
| $16.65 | $23.45 | $35.77 | +72% | Bullish | |
| $18.41 | $26.57 | $41.56 | +95% | Bullish | |
| $20.16 | $29.75 | $47.59 | +118% | Bullish | |
| $24.89 | $37.53 | $61.26 | +175% | Bullish | |
| $27.91 | $42.94 | $71.42 | +215% | Bullish | |
| $25.32 | $39.74 | $67.23 | +192% | Bullish | |
| $39.52 | $67.86 | $123.34 | +398% | Bullish | |
| $57.62 | $116.20 | $234.14 | +753% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.71 | $13.63 | $17.15 | +0.00% |
| August 2026 | $12.31 | $14.62 | $17.90 | +7.27% |
| September 2026 | $12.32 | $14.77 | $18.33 | +1.01% |
| October 2026 | $12.95 | $15.64 | $19.63 | +5.87% |
| November 2026 | $13.31 | $16.18 | $20.51 | +3.46% |
| December 2026 | $12.97 | $15.85 | $20.27 | -2.00% |
Click any year to see its month-by-month OCS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OCS price prediction for 2026 points to an average of $13.63 (low $10.71, high $20.27) — a potential gain of 0% on today's $13.63. Price action looks broadly range-bound.
In 2027, OCS is projected to trade between $14.81 and $26.07, averaging $19.03 — a potential gain of +40% from today's $13.63. That is up +40% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Oculis Holding AG's 2028 outlook centres on $23.21, within a $17.43 to $33.23 range. That is up +22% on the projected 2027 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2029, OCS could reach as high as $35.92, with a base case around $24.23 and support toward $17.67 — roughly +78% from $13.63. Buyers look set to stay in control over this stretch.
Expect OCS to range from $16.65 to $35.77 through 2030. The $23.45 average target implies a +72% move from current prices. That is -3% versus the projected 2029 average. Momentum favours further upside here.
The OCS price prediction for 2031 points to an average of $26.57 (low $18.41, high $41.56) — a potential gain of +95% on today's $13.63. Buyers look set to stay in control over this stretch.
In 2032, OCS is projected to trade between $20.16 and $47.59, averaging $29.75 — a potential gain of +118% from today's $13.63. That is up +12% on the projected 2031 average. Momentum favours further upside here.
Oculis Holding AG's 2033 outlook centres on $37.53, within a $24.89 to $61.26 range. That is up +26% on the projected 2032 average. That marks a +175% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, OCS could reach as high as $71.42, with a base case around $42.94 and support toward $27.91 — roughly +215% from $13.63. Momentum favours further upside here.
Expect OCS to range from $25.32 to $67.23 through 2035. The $39.74 average target implies a +192% move from current prices. That is -7% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The OCS price prediction for 2040 points to an average of $67.86 (low $39.52, high $123.34) — a potential gain of +398% on today's $13.63. Momentum favours further upside here.
In 2050, OCS is projected to trade between $57.62 and $234.14, averaging $116.20 — a potential gain of +753% from today's $13.63. That is up +71% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OCS today (≈ 73.367572 OCS) could be worth
$8,525.01
+$7,525.01 (+753%) by 2050 · US Dollar
Based on the average projected OCS price of $116.2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OCSwould be worth at today's price.
$1,000 invested in OCS on Jul 10, 2025 (≈ 54.347827 OCS) would be worth
$740.76
-$259.24 (-25.9%) today · 0.74× · US Dollar
Based on a OCS entry price of $18.4 vs. today's $13.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.12 | $965.3 | -3.5% |
| 1 month ago | $10.97 | $1,242.48 | +24.2% |
| 3 months ago | $27.3 | $499.27 | -50.1% |
| 6 months ago | $23.15 | $588.77 | -41.1% |
| 1 year ago | $18.4 | $740.76 | -25.9% |
| All time (5.0y) ago | $9.69 | $1,406.6 | +40.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OCS forecast.
Our base-case forecast reaches $27.00 around 2032.
Implied market cap at $27.00: $1.63B
The multi-year forecast shows a bullish tilt in most years, with 2026 marked as Neutral. The outlook becomes increasingly bullish from 2027 onward, with rising average prices and higher potential returns. For 2027 the average price is $20.72 and the ROI is 46.7%, indicating meaningful upside if the trend continues.
By 2030 the average price is $24.96 and the ROI is 76.8%, reflecting continued upside. By 2040 the average price is $75.35 with ROI 433.6%, and by 2050 the average price is $127.33 with ROI 801.8%, signaling substantial long-term upside amid bullish sentiment.
Tap a question to reveal the answer.
Avg price: $24.96; min: $17.12; max: $39.47; ROI: 76.8%; sentiment: BULLISH.
Forecast sentiment is Neutral in 2026 and BULLISH from 2027 through 2050, with ROI rising to 801.8% by 2050, suggesting upside potential but not a guarantee.
Yes. The forecast max reaches $53.56 in 2032, with higher maxima in later years (2033 max $70.91; 2034 max $81.70; 2040 max $144.37; 2050 max $272.85).
Current price is $14.12; market cap is $852.68M.
Bullish sentiment with RSI14 at 40; SMA50 is $21.07 and SMA200 is $22.61. Support is at $10.71 and resistance at $31.00. The 30-day range is $10.92 to $18.25, and annualized volatility is 70%.
Oculis Holding AG Community Discussion
0Share your Oculis Holding AG price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.